A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants
The SARS-CoV-2 pandemic has spread to all parts of the world and can cause life-threatening pneumonia and other severe disease manifestations known as COVID-19. This health crisis has resulted in a significant effort to stop the spread of this new coronavirus. However, while propagating itself in th...
Main Authors: | Niklas Vesper, Yaneth Ortiz, Frauke Bartels-Burgahn, Jianying Yang, Kathrin de la Rosa, Matthias Tenbusch, Sebastian Schulz, Stephanie Finzel, Hans-Martin Jäck, Hermann Eibel, Reinhard E. Voll, Michael Reth |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.730766/full |
Similar Items
-
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
by: Qizhong Lu, et al.
Published: (2021-01-01) -
Neutralizing antibodies targeting SARS-CoV-2 spike protein
by: Shi Xiaojie, et al.
Published: (2021-01-01) -
Design, Expression, Purification, and Characterization of a YFP-Tagged 2019-nCoV Spike Receptor-Binding Domain Construct
by: Tobias Bierig, et al.
Published: (2020-12-01) -
Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis
by: Margherita Passariello, et al.
Published: (2021-08-01) -
Purification and characterization of the receptor‐binding domain of SARS‐CoV‐2 spike protein from Escherichia coli
by: Yunxia He, et al.
Published: (2021-06-01)